EW 8-K 2026-11-04

Edwards Lifesciences Corp (EW) 8-K dated 2026-11-04 — accession 0001099800-26-000053.

Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.

Edwards Lifesciences Corp filed a 8-K on 2026-11-04. Accession 0001099800-26-000053.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported EW revenue for 2025-12-31 was $6.07B. Net income was $1.07B. Revenue was up 1.0% from 2023-12-31 to 2025-12-31. EW currently screens at market cap $49.91B and trailing P/E 58.0.

Not investment advice. The EW SEC hub lists recent forms. The stock page is the research view.